Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis (Q38081967)

28 August 2017

Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis (English)

1 reference

28 August 2017

1 reference

1 reference

Charles Richardson

1

1 reference

28 August 2017

Robert F Bargatze

series ordinal

2

1 reference

28 August 2017

Robert Goodwin

series ordinal

3

1 reference

28 August 2017

Paul M Mendelman

series ordinal

4

1 reference

28 August 2017

1 February 2013

1 reference

Expert Review of Vaccines

28 August 2017

1 reference

28 August 2017

12

1 reference

28 August 2017

155-167

1 reference

28 August 2017

2

1 reference

Noroviruses: a comprehensive review

28 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Noroviruses: the perfect human pathogens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Pathogenesis of noroviruses, emerging RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus-like particles as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Noroviruses - State of the Art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Viral shape-shifting: norovirus evasion of the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Foodborne viral gastroenteritis: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

The potential economic value of a human norovirus vaccine for the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

The discovery of the 27-nm Norwalk virus: an historic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus genome cloning and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Are noroviruses emerging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus disease associated with excess mortality and use of statins: a retrospective cohort study of an outbreak following a pilgrimage to Lourdes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Systematic literature review of role of noroviruses in sporadic gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus: how infectious is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus shedding after experimental human infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Duration of norovirus excretion and the longitudinal course of viral load in norovirus-infected elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Environmental transmission of norovirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus open reading frame 3 encodes a minor structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

X-ray crystallographic structure of the Norwalk virus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Molecular evolution of GII-4 Norovirus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

In vitro cell culture infectivity assay for human noroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Laboratory efforts to cultivate noroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Experimental norovirus infections in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Experimental infection of Macaca nemestrina with a Toronto Norwalk-like virus of epidemic viral gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Chimpanzees as an animal model for human norovirus infection and vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Binding patterns of human norovirus-like particles to buccal and intestinal tissues of gnotobiotic pigs in relation to A/H histo-blood group antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus classification and proposed strain nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Clinical Immunity in Acute Gastroenteritis Caused by Norwalk Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus infection and disease is associated with ABO histo-blood group type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Human susceptibility and resistance to Norwalk virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Serological correlate of protection against norovirus-induced gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus vaccine against experimental human Norwalk Virus illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Cellular and humoral immunity following Snow Mountain virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus-host interaction: multi-selections by human histo-blood group antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Mechanisms of GII.4 norovirus persistence in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Immunogenetic mechanisms driving norovirus GII.4 antigenic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Infection of calves with bovine norovirus GIII.1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Physical stabilization of Norwalk virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

Purification of norovirus-like particles (VLPs) by ion exchange chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.145

21 January 2018

Identifiers

DOI

10.1586/ERV.12.145

1 reference

28 August 2017

1 reference